http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100129774-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b84e047c432bb6f65188db21825854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f8c1e0a566cefa89054b051c2f64a36 |
| publicationDate | 2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100129774-A |
| titleOfInvention | Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo [1,2-a] pyridine, and their preparation and therapeutic uses |
| abstract | The present invention relates to compounds of formula (I) as addition salts with bases or acids: <Formula I> Where R 1 is a phenyl group or a naphthyl group optionally substituted with one or a plurality of atoms or groups; X is halogen, (C 1 -C 10 ) alkyl, halo (C 1 -C 10 ) alkyl, (C 1 -C 10 ) alkoxy, NRaRb, cyano or nitro (wherein (C 1 -C 10 ) alkyl is One to four substituents, identical to or different from one another, selected from halogen or NRaRb or a hydroxyl group); R2 and R3 are each independently a hydrogen atom or a (C 1 -C 10 ) alkyl group optionally substituted with a Rf group; From halogen or (C 1 -C 10 ) alkyl, halo (C 1 -C 10 ) alkyl, (C 1 -C 10 ) alkoxy, halo (C 1 -C 10 ) alkoxy, NRaRb, hydroxyl, nitro or cyano group An aryl group optionally substituted with one or a plurality of substituents selected; R2 and X together with the carbon atoms to which they are attached may form a carbocyclic ring having 5 to 7 carbon atoms; R 4 is a hydrogen atom, a (C 1 -C 10 ) alkyl group optionally substituted with an Rf group, or an optionally substituted aryl group. The present invention is used in therapy and synthetic methods. |
| priorityDate | 2008-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 425.